Tadashi Kamei
Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Effectiveness of indacaterol/glycopyrronium/mometasone for refractory asthmatic cough after switching from inhaled corticosteroid/long-acting β2-agonist therapy.
Journal: The journal of allergy and clinical immunology. Global
Published: December 26, 2024
Long-term safety and exploratory efficacy of fevipiprant in patients with inadequately controlled asthma: the SPIRIT randomised clinical trial.
Journal: Respiratory research
Published: August 16, 2021
Randomised trial of the P2X3 receptor antagonist sivopixant for refractory chronic cough.
Journal: The European respiratory journal
Published: March 11, 2021
Clinical benefit of two-times-per-day aclidinium bromide compared with once-a-day tiotropium bromide hydrate in COPD: a multicentre, open-label, randomised study.
Journal: BMJ open
Published: July 28, 2019
Asthma mortality based on death certificates: A demographic survey in Kagawa, Japan.
Journal: Respiratory investigation
Published: August 04, 2018
Efficacy and safety of benralizumab in Japanese patients with severe, uncontrolled eosinophilic asthma.
Journal: Allergology international : official journal of the Japanese Society of Allergology
Published: August 14, 2017
Stratifying the risk of COPD exacerbation using the modified Medical Research Council scale: a multicenter cross-sectional CAP study.
Journal: Respiratory investigation
Published: August 14, 2014
Ongoing allergic rhinitis impairs asthma control by enhancing the lower airway inflammation.
Journal: The journal of allergy and clinical immunology. In practice
Published: July 16, 2013
Showing 1-8 of 8
Last Updated: 09/26/2026